Sponsors (48)
Introduced April 10, 2025 by David G. Valadao · Last progress April 10, 2025
The bill strengthens patient protections, access, and clinical support for Medicare oxygen users (including RT coverage and supplier service requirements) but increases Medicare spending and adds compliance and implementation burdens that may raise costs and risk reduced local supplier availability, especially in rural and non‑contiguous areas.
Medicare beneficiaries who use supplemental oxygen will get more reliable, clinically supportive supplier services (education, delivery, set-up, monitoring, timely repairs/replacements, 24‑hour on‑call service, emergency/back‑up supplies) and the ability to choose or change qualified local suppliers, improving safety and continuity of care.
Medicare will cover respiratory therapist services (with an add‑on payment), lowering out‑of‑pocket costs for beneficiaries and improving clinical care by better compensating these providers.
Payments and audit rules include protections (a liquid‑oxygen payment floor indexed to CPI and limits on aggressive retrospective clinical inference), which should stabilize supplier revenue and reduce abrupt service interruptions.
Taxpayers and the Medicare program will face increased spending because the bill creates non‑budget‑neutral add‑on payments (for high‑flow oxygen and for respiratory therapist services), which may pressure federal budgets or require offsets.
Small and rural suppliers (and beneficiaries in rural, non‑contiguous, and territorial areas) risk reduced reimbursement or being driven from the market due to geographic payment blends, incomplete payment rules for non‑contiguous areas, and strict new coverage/compliance requirements, threatening local access.
Suppliers, prescribers, and contractors will face substantial new administrative and compliance burdens (expanded scope/monitoring/documentation, required electronic templates, disclosure and reporting), raising operating costs and billing complexity.
Based on analysis of 8 sections of legislative text.
Removes supplemental oxygen from Medicare competitive bidding, sets new area-based payments, adds respiratory therapist payment, requires electronic templates, notices, and beneficiary protections starting 2026.
Removes supplemental oxygen and related equipment from Medicare’s competitive bidding program and establishes new Medicare payment rules for oxygen products and services beginning January 1, 2026. It creates area‑based payment formulas (including special rules for rural, noncontiguous, and other areas), requires a separate payment for liquid oxygen, adds respiratory therapist services as a covered Part B service with a monthly add‑on payment, mandates electronic templates and notices for medical necessity and rental-period tracking, restores older audit clinical-inference standards, and requires enumerated beneficiary rights and supplier obligations for oxygen services.